Search

Your search keyword '"Shankar-Hari, Manu"' showing total 1,026 results

Search Constraints

Start Over You searched for: Author "Shankar-Hari, Manu" Remove constraint Author: "Shankar-Hari, Manu"
1,026 results on '"Shankar-Hari, Manu"'

Search Results

102. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial

104. Albumin versus Balanced Crystalloid for the early resuscitation of sepsis: a randomised feasibility trial. The ABC-Sepsis Trial.

105. A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2

106. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial

107. Estimating the attributable fraction of mortality from acute respiratory distress syndrome to inform enrichment in future randomised clinical trials

110. Stimulation of platelet P2Y1 receptors by different endogenous nucleotides leads to functional selectivity via biased signalling.

112. Estimating the attributable fraction of mortality from acute respiratory distress syndrome to inform enrichment in future randomised clinical trials

114. Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort study

115. Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study

116. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

117. A second update on mapping the human genetic architecture of COVID-19

118. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

120. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19

122. Whole-genome sequencing reveals host factors underlying critical COVID-19

130. An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)

132. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

135. Improving risk prediction model quality in the critically ill: data linkage study

136. Role of immunosuppression in an antibiotic stewardship intervention and its association with clinical outcomes and antibiotic use: protocol for an observational study (RISC-sepsis)

137. Supplemental Material - Albumin versus balanced crystalloid for resuscitation in the treatment of sepsis: A protocol for a randomised controlled feasibility study, 'ABC-Sepsis'

138. Additional file 1 of Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi

139. Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

142. Prevalence, risk factors, and treatments for post-COVID breathlessness:a systematic review and meta-analysis

143. Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial

144. Viral coinfections in hospitalized Coronavirus disease 2019 patients recruited to the international severe acute respiratory and emerging infections consortium WHO clinical characterisation protocol UK study

145. Could treatment with immunomodulatory agents targeting IL-1, IL-6, or JAK signalling improve outcomes in patients with severe influenza pneumonia? A systematic and narrative review

146. High plasma IL-18 identifies high-risk ARDS patients not identified by latent class analysis sub-phenotyping: a secondary analysis of the SAILS and HARP-2 studies

147. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis

149. Highly sensitive lineage discrimination of SARS-CoV-2 variants through allele-specific probe PCR

Catalog

Books, media, physical & digital resources